Controversially, an in vitro study showed that K562 leukemia and H1299 lung cancer cell with ALDH1A2 overexpression exhibited higher cell proliferation rates, higher clonal efficiency, and increased drug resistance to 4-hydroperoxycyclophosphamide and doxorubicin [33]. Here, ALDH1A2 is linked to lung carcinoma.